Study of Recombinant Human Thrombin for Bleeding During Autologous Skin Grafting

NCT00371215 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
72
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

ZymoGenetics